Literature DB >> 8510924

TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.

G Foos1, S Natour, K H Klempnauer.   

Abstract

The oncogene v-myb and its cellular progenitor c-myb encode nuclear, DNA-binding phosphoproteins that function as transcriptional regulators. Previous studies have demonstrated the existence of two distinct transactivation mechanisms for Myb-inducible promoters. One of these mechanisms, exemplified by the chicken mim-1 promoter, involves specific binding of Myb protein to Myb binding sites located upstream of the transcriptional start site. A second mechanism, exemplified by the human HSP70 promoter, does not require the presence of specific Myb binding sites. Here, we have more closely investigated transactivation of the human HSP70 promoter by Myb proteins. Mutational analysis of the human HSP70 promoter failed to show a correlation between Myb-inducibility and the presence of a particular upstream transcription factor binding site, but instead showed that Myb-inducibility was dependent on the presence of a particular type of TATA-box. This suggests that the TATA-box is involved in transactivation by v-Myb and that only a subset of TATA-boxes confers Myb-inducibility. Activation of the HSP70 promoter is dependent on the presence of most of the carboxy terminal amino acid sequences of v-Myb, including the previously identified acidic transactivation domain and a putative leucine-zipper region. Finally, we show that the HSP70 promoter is activated in a Myb binding site independent fashion not only by v-Myb, but also by chicken c-Myb and chicken B-Myb. These observations raise the possibility that the ability to transactivate in a Myb binding-site independent manner is a common property among Myb proteins. Since chicken B-Myb has been shown previously to be unable to transactivate a Myb binding-site containing promoter, such as the mim-1 promoter (Foos et al., 1992), our results also show that both modes of transactivation are independent of each other.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510924

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.

Authors:  Xiaolin Li; Donald P McDonnell
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  A novel G1-specific enhancer identified in the human heat shock protein 70 gene.

Authors:  T Taira; T Narita; S M Iguchi-Ariga; H Ariga
Journal:  Nucleic Acids Res       Date:  1997-05-15       Impact factor: 16.971

3.  Activation of human B-MYB by cyclins.

Authors:  A Sala; M Kundu; I Casella; A Engelhard; B Calabretta; L Grasso; M G Paggi; A Giordano; R J Watson; K Khalili; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 4.  Chaperones in cell cycle regulation and mitogenic signal transduction: a review.

Authors:  K Helmbrecht; E Zeise; L Rensing
Journal:  Cell Prolif       Date:  2000-12       Impact factor: 6.831

5.  Physical interaction between retinoic acid receptor and the oncoprotein myb inhibits retinoic acid-dependent transactivation.

Authors:  E Pfitzner; J Kirfel; P Becker; A Rolke; R Schüle
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 6.  B-Myb, cancer, senescence, and microRNAs.

Authors:  Ivan Martinez; Daniel Dimaio
Journal:  Cancer Res       Date:  2011-08-09       Impact factor: 12.701

7.  The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties.

Authors:  S Bergholtz; T O Andersen ; K B Andersson; J Borrebaek; B Lüscher; O S Gabrielsen
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

8.  The carboxyterminus of human c-myb protein stimulates activated transcription in trans.

Authors:  G Vorbrueggen; F Kalkbrenner; S Guehmann; K Moelling
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

9.  In vivo growth of a murine lymphoma cell line alters regulation of expression of HSP72.

Authors:  S Davidson; P Høj; T Gabriele; R L Anderson
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

10.  Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity.

Authors:  P Salomoni; D Perrotti; R Martinez; C Franceschi; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.